Off-Label Use of Second-Generation Antipsychotics in Borderline Personality Disorder: A Survey of Italian Psychiatrists
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Off-Label Use of Second-Generation Antipsychotics in Borderline Personality Disorder: A Survey of Italian Psychiatrists
Authors
Keywords
-
Journal
JOURNAL OF PERSONALITY DISORDERS
Volume 35, Issue 3, Pages 321-335
Publisher
Guilford Publications
Online
2019-10-14
DOI
10.1521/pedi_2019_33_445
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Medication Management for Patients With Borderline Personality Disorder
- (2018) John G. Gunderson et al. AMERICAN JOURNAL OF PSYCHIATRY
- Factors associated with first- versus second-generation long-acting antipsychotics prescribed under ordinary clinical practice in Italy
- (2018) Giovanni Ostuzzi et al. PLoS One
- International trends in antipsychotic use: A study in 16 countries, 2005–2014
- (2017) Óskar Hálfdánarson et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Pharmacological treatment of borderline personality disorder: a retrospective observational study at inpatient unit in Italy
- (2016) Enrico Paolini et al. INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
- The Canadian Journal of Psychiatry in 2014 and beyond
- (2015) Scott B Patten CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
- Off-Label Prescribing of Antipsychotics in Adults, Children and Elderly Individuals: A Systematic Review of Recent Prescription Trends
- (2015) Louise Carton et al. CURRENT PHARMACEUTICAL DESIGN
- Psychopharmacological treatment of 2195 in-patients with borderline personality disorder: A comparison with other psychiatric disorders
- (2015) René Bridler et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Effectiveness of long-acting paliperidone palmitate in borderline personality disorder
- (2015) Nerea Palomares et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- The Use of Psychotropic Medication in Patients With Emotionally Unstable Personality Disorder Under the Care of UK Mental Health Services
- (2015) Carol Paton et al. JOURNAL OF CLINICAL PSYCHIATRY
- Treatment of personality disorder
- (2015) Anthony W Bateman et al. LANCET
- Pharmacotherapy in the treatment of patients with borderline personality disorder
- (2013) Moritz Knappich et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Effectiveness and tolerability of long-acting intramuscular risperidone as adjuvant treatment in refractory borderline personality disorder
- (2012) J. L. Carrasco et al. PSYCHOPHARMACOLOGY
- Psychotropic Medications and Informed Consent: A Review
- (2011) Bradford Frank et al. Annals of Clinical Psychiatry
- Medication for borderline personality disorder: A survey at a secure hospital
- (2011) Camilla Haw et al. INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
- Pharmacotherapy for borderline personality disorder: NICE guideline
- (2010) Tim Kendall et al. BRITISH JOURNAL OF PSYCHIATRY
- Pharmacotherapy for borderline personality disorder: Cochrane systematic review of randomised trials
- (2010) Klaus Lieb et al. BRITISH JOURNAL OF PSYCHIATRY
- A naturalistic study of changes in pharmacological prescription for borderline personality disorder in clinical practice: from APA to NICE guidelines
- (2010) Juan C. Pascual et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Borderline personality disorder
- (2010) Falk Leichsenring et al. LANCET
- Prevalence, Correlates, Disability, and Comorbidity of DSM-IV Borderline Personality Disorder
- (2009) Bridget F. Grant et al. JOURNAL OF CLINICAL PSYCHIATRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started